BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27876876)

  • 21. A combination of glioma in vivo imaging and in vivo drug delivery by metal-organic framework based composite nanoparticles.
    Pan YB; Wang S; He X; Tang W; Wang J; Shao A; Zhang J
    J Mater Chem B; 2019 Dec; 7(48):7683-7689. PubMed ID: 31778139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A versatile and multifunctional metal-organic framework nanocomposite toward chemo-photodynamic therapy.
    Pan Y; Luo Z; Wang X; Chen Q; Chen J; Guan Y; Liu D; Xu H; Liu J
    Dalton Trans; 2020 Apr; 49(16):5291-5301. PubMed ID: 32242552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
    Cheng M; Ma D; Zhi K; Liu B; Zhu W
    Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
    Lakkakula JR; Matshaya T; Krause RW
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of PLGA/chitosan/zeolites and PLGA/chitosan/metal organic frameworks nanofibers for targeted delivery of Paclitaxel toward prostate cancer cells death.
    Faraji Dizaji B; Hasani Azerbaijan M; Sheisi N; Goleij P; Mirmajidi T; Chogan F; Irani M; Sharafian F
    Int J Biol Macromol; 2020 Dec; 164():1461-1474. PubMed ID: 32735933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Luminescent Mg-Metal-Organic Framework for Sustained Release of 5-Fluorouracil: Appropriate Host-Guest Interaction and Satisfied Acid-Base Resistance.
    Hu Z; Qiao C; Xia Z; Li F; Han J; Wei Q; Yang Q; Xie G; Chen S; Gao S
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14914-14923. PubMed ID: 32105065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Application of MOF-808 Decorated with Folic Acid-Conjugated Chitosan as a Strong Nanocarrier for the Targeted Drug Delivery of Quercetin.
    Parsaei M; Akhbari K
    Inorg Chem; 2022 Dec; 61(48):19354-19368. PubMed ID: 36383693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of Versatile Hollow Metal-Organic Framework Nanoplatforms for Folate-Targeted and Combined Cancer Imaging and Therapy.
    Zeng X; Chen B; Song Y; Lin X; Zhou SF; Zhan G
    ACS Appl Bio Mater; 2021 Aug; 4(8):6417-6429. PubMed ID: 35006919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
    Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
    Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MOF-801 as a Nanoporous Water-Based Carrier System for In Situ Encapsulation and Sustained Release of 5-FU for Effective Cancer Therapy.
    Parsaei M; Akhbari K
    Inorg Chem; 2022 Apr; 61(15):5912-5925. PubMed ID: 35377632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid fabrication of carbon quantum dots as multifunctional nanovehicles for dual-modal targeted imaging and chemotherapy.
    Chiu SH; Gedda G; Girma WM; Chen JK; Ling YC; Ghule AV; Ou KL; Chang JY
    Acta Biomater; 2016 Dec; 46():151-164. PubMed ID: 27662808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro evaluation of 5-flourouracil loaded magnetite-zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications.
    Sağir T; Huysal M; Durmus Z; Kurt BZ; Senel M; Isık S
    Biomed Pharmacother; 2016 Feb; 77():182-90. PubMed ID: 26796283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postsynthetic Modification of ZIF-90 for Potential Targeted Codelivery of Two Anticancer Drugs.
    Zhang FM; Dong H; Zhang X; Sun XJ; Liu M; Yang DD; Liu X; Wei JZ
    ACS Appl Mater Interfaces; 2017 Aug; 9(32):27332-27337. PubMed ID: 28745483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery.
    Javanbakht S; Hemmati A; Namazi H; Heydari A
    Int J Biol Macromol; 2020 Jul; 155():876-882. PubMed ID: 31805324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
    Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X
    Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of surfactant-modified ZIF-8 with controllable microstructures and their drug loading and sustained release behaviour.
    Xu X; Liu Y; Guo Z; Song XZ; Qi X; Dai Z; Tan Z
    IET Nanobiotechnol; 2020 Sep; 14(7):595-601. PubMed ID: 33010135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.
    Jiang K; Zhang L; Hu Q; Zhang Q; Lin W; Cui Y; Yang Y; Qian G
    Chemistry; 2017 Jul; 23(42):10215-10221. PubMed ID: 28682004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Delivery of 5-Fluorouracil and Sonidegib via Surface-Modified ZIF-8 MOFs for Effective Basal Cell Carcinoma Therapy.
    Padya BS; Fernandes G; Hegde S; Kulkarni S; Pandey A; Deshpande PB; Ahmad SF; Upadhya D; Mutalik S
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.